In a clinical trial, the pump showed 97 percent clinical accuracy in the delivery of the physician-programmed dosage. The new pump design is intended to increase longevity and accuracy through the elimination of moving parts and complex gears and rotors.
Related Articles on Pain Management:
10 Trends in ASC Pain Management Case Revenue Based on Facility Size From 2007-2010
Fees Set for Sarasota County Florida Pain Clinics Breaking Regulations
6 Points for Physicians on Identifying and Preventing Chronic Pain Medication Abuse
FDA Approves Medasys Implantable Programmable Drug Pump for Pain Management
The FDA approved Medasys’ Prometra programmable implantable drug pump for the intraspinal delivery of INFUMORPH, a preservative-free morphine sulfate sterile solution, for the management of pain, according to a news release.
